Outer membrane protein changes and efflux pump expression together may confer resistance to ertapenem in Enterobacter cloacae

Antimicrob Agents Chemother. 2006 Aug;50(8):2833-5. doi: 10.1128/AAC.01591-05.

Abstract

We investigated ertapenem-susceptible and -resistant extended-spectrum beta-lactamase-producing Enterobacter cloacae isolates obtained from the same patient. Gene transcription of OmpD and OmpF was diminished in the ertapenem-resistant isolate. An efflux pump inhibitor decreased the MICs of ertapenem in the resistant strain, suggesting a potential role of efflux pumps in ertapenem resistance.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Bacterial Outer Membrane Proteins / metabolism*
  • Drug Resistance, Microbial / genetics
  • Enterobacter cloacae / drug effects*
  • Enterobacter cloacae / genetics
  • Enterobacter cloacae / isolation & purification
  • Ertapenem
  • Gene Expression Regulation, Bacterial
  • Genes, Bacterial
  • Humans
  • Membrane Transport Proteins / metabolism*
  • Microbial Sensitivity Tests
  • Transcription, Genetic
  • beta-Lactams / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Bacterial Outer Membrane Proteins
  • Membrane Transport Proteins
  • beta-Lactams
  • Ertapenem